Page 137 - GPD-3-3
P. 137

Gene & Protein in Disease                                              Association of GST1 with lung cancer



            Methodology: Arpan Saha, Madhurima Sinha, Susweta Roy  accessed on 2024 Sep 23].
            Resources: Somsubhra Nath                          7.   Byun J, Han Y, Li Y, et al. Cross-ancestry genome-wide meta-
            Writing – original draft: Arpan Saha                  analysis of 61,047 cases and 947,237 controls identifies new
            Writing – review & editing: Mainak Sengupta           susceptibility loci contributing to lung cancer.  Nat Genet.
                                                                  2022;54(8):1167-1177.
            Ethics approval and consent to participate
                                                                  doi: 10.1038/s41588-022-01115-x
            The study protocol involving human subjects was approved   8.   Sato M, Shames DS, Gazdar AF, Minna JD. A translational
            by the Ethics Committee of Saroj Gupta Cancer Centre and   view of the molecular pathogenesis of lung cancer. J Thorac
            Research Institute (IEC SGCCRI Ref No-2017/MS/1; dated:   Oncol. 2007;2(4):327-343.
            October 11, 2017), the Ethics Committee of IPGME&R      doi: 10.1097/01.JTO.0000263718.69320.4c
            (Memo No. Inst/IEC/2015/545; dated: December 10,
            2015), and the Ethics Committee of the University of   9.   Sun S, Schiller JH, Spinola M, Minna JD. New molecularly
            Calcutta (Ref No: 0024/16-117/1434; dated: October    targeted therapies for lung cancer.  J  Clin Invest.
            24, 2016) in Kolkata, India. The approval was granted in   2007;117(10):2740-2750.
            accordance with the regulations of the Indian Council of      doi: 10.1172/JCI31809
            Medical Research (ICMR) and followed the Declaration   10.  Long E, Patel H, Byun J, Amos CI, Choi J. Functional studies
            of Helsinki, 1964. Informed consent was obtained from all   of lung cancer GWAS beyond association. Hum Mol Genet.
            individual participants included in the study.        2022;31(R1):R22-R36.

            Consent for publication                               doi: 10.1093/hmg/ddac140
                                                               11.  Van Dyck E, Nazarov PV, Muller A, et al. Bronchial airway
            The study subjects gave consent to publish their data.
                                                                  gene expression in smokers with lung or head and neck
            Availability of data                                  cancer. Cancer Med. 2014;3(2):322-336.
                                                                  doi: 10.1002/cam4.190
            All data generated or analyzed during this study are
            available from the corresponding author on reasonable   12.  Hammouz RY, Kostanek JK, Dudzisz A, Witas P,
            request.                                              Orzechowska M, Bednarek AK. Differential expression
                                                                  of lung adenocarcinoma transcriptome with signature of
            References                                            tobacco exposure. J Appl Genet. 2020;61(3):421-437.
            1.   Singh N, Agrawal S, Jiwnani S, et al. Lung cancer in India.      doi: 10.1007/s13353-020-00569-1
               J Thorac Oncol. 2021;16(8):1250-1266.           13.  Bozhilov YK, Downes DJ, Telenius J,  et al. A  gain-of-
               doi: 10.1016/j.jtho.2021.02.004                    function single nucleotide variant creates a new promoter
                                                                  which acts as an orientation-dependent enhancer-blocker.
            2.   United States. Public Health Service. Office of the Surgeon   Nat Commun. 2021;12(1):3806.
               General. How Tobacco Smoke Causes Disease : The Biology
               and Behavioral Basis for Smoking-Attributable Disease :      doi: 10.1038/s41467-021-23980-6
               A Report of the Surgeon General. U.S: Department of Health   14.  Kotnis A, Sarin R, Mulherkar R. Genotype, phenotype and
               and Human Services, Public Health Service, Office of the   cancer: Role of low penetrance genes and environment in
               Surgeon General; 2010.                             tumour susceptibility. J Biosci. 2005;30:93-102.
            3.   Department of Health and Human Services.  The Health      doi: 10.1007/BF02705154
               Consequences of Smoking - 50 Years of Progress: A Report of
               the Surgeon General. Available from: https://www.cdc.gov/  15.  Pfeifer  GP,  Denissenko  MF,  Olivier  M,  Tretyakova  N,
               tobacco [Last accessed on 2024 Sep 23].            Hecht SS, Hainaut P. Tobacco smoke carcinogens, DNA
                                                                  damage and p53 mutations in smoking-associated cancers.
            4.   Mathur P, Sathishkumar K, Chaturvedi M,  et al. Cancer   Oncogene. 2002;21:7435-7451.
               Statistics, 2020: Report from national cancer registry
               programme, India. JCO Glob Oncol. 2020;6:1063-1075.     doi: 10.1038/sj.onc.1205803
                                                               16.  Leanderson P, Tagesson C. Cigarette smoke-induced DNA
               doi: 10.1200/GO.20.00122
                                                                  damage in cultured human lung cells: Role of hydroxyl
            5.   Schwartz AG. Genetic epidemiology of cigarette smoke-  radicals and endonuclease activation.  Chem Biol Interact.
               induced lung disease. Proc Am Thorac Soc. 2012;9:22-26.  1992;81:197-208.
               doi: 10.1513/pats.201106-037MS                     doi: 10.1016/0009-2797(92)90034-i
            6.   Ankathil R. Tobacco, Genetic Susceptibility and Lung Cancer.   17.  Sengupta D, Mukhopadhyay P, Banerjee S, et al. Identifying
               Vol.  2010. Available from: https://www.la-press.com [Last   polymorphic cis-regulatory variants as risk markers for lung


            Volume 3 Issue 3 (2024)                         7                               doi: 10.36922/gpd.3928
   132   133   134   135   136   137   138   139   140   141   142